FLGT offering history
Every offering-related filing in Fulgent Genetics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 653 filings back to Jun 9, 2016.
| Date | Filing | What it means | |
|---|---|---|---|
| Nov 20, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 25, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 12, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 5, 2020 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Aug 5, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 21, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 6, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 15, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 13, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 30, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 23, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 12, 2019 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Sep 29, 2016 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Sep 28, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 28, 2016 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Sep 28, 2016 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 26, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 26, 2016 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Sep 19, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 2, 2016 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
FLGT offering FAQ
When did FLGT last execute an offering?
Per SEC filings, Fulgent Genetics, Inc.'s most recent priced offering document is a 424B5 filed 2020-11-20. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did FLGT last announce or register an offering?
The most recent registration is a S-3/A filed 2020-08-05. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.